ebselen

NEWENTRY ; Severe acute respiratory syndrome-related coronavirus







6 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33400086 COVID-19: inflammatory responses, structure-based drug design and potential therapeutics. 2022 Feb 1
2 33915460 Ebsulfur and Ebselen as highly potent scaffolds for the development of potential SARS-CoV-2 antivirals. 2021 Jul 1
3 34031399 Inhibition mechanism of SARS-CoV-2 main protease by ebselen and its derivatives. 2021 May 24 2
4 34575955 The Se-S Bond Formation in the Covalent Inhibition Mechanism of SARS-CoV-2 Main Protease by Ebselen-like Inhibitors: A Computational Study. 2021 Sep 10 5
5 32598985 Potential therapeutic use of ebselen for COVID-19 and other respiratory viral infections. 2020 Aug 20 1
6 32911432 Site mapping and small molecule blind docking reveal a possible target site on the SARS-CoV-2 main protease dimer interface. 2020 Dec 1